News & Updates
Showing Pharmacy articles
Showing
Osimertinib plus chemo bumps up PFS in advanced EGFR-mutated NSCLC
In the first-line treatment of patients with advanced nonsmall cell lung cancer (NSCLC) harbouring EGFR mutation, the combination of osimertinib plus pemetrexed and platinum-based chemotherapy outperformed osimertinib alone in terms of extending progression-free survival (PFS), according to the interim results of the phase III FLAURA2 trial presented at WCLC 2023.
Osimertinib plus chemo bumps up PFS in advanced EGFR-mutated NSCLC
12 Oct 2023
MOH, NGOs join forces to prevent youths from smoking, vaping
The first intervention program to target Malaysian B40 youth and their parents aims to educate them on the dangers of smoking and vaping.
MOH, NGOs join forces to prevent youths from smoking, vaping
12 Oct 2023
Do antiemetic drugs prevent chemotherapy-induced nausea, vomiting in cancer patients?
Cancer patients who are being treated with chemotherapy are susceptible to chemotherapy-induced nausea and vomiting (CINV), and they continue to experience these side effects despite being administered with antiemetics, a study has shown.
Do antiemetic drugs prevent chemotherapy-induced nausea, vomiting in cancer patients?
11 Oct 2023
Ginseng may protect breast cancer patients against doxorubicin-induced cardiac toxicity
Supplementation with ginseng appears to provide protective benefits against early cancer therapeutics-related cardiac dysfunction caused by doxorubicin and may help prevent early decline in left ventricular ejection fraction in patients with breast cancer, suggests a study.
Ginseng may protect breast cancer patients against doxorubicin-induced cardiac toxicity
10 Oct 2023
ALA-PDT on par with minocycline for moderate-to-severe rosacea
Patients with moderate-to-severe rosacea may benefit from treatment with 5-aminolevulinic acid photodynamic therapy (ALA-PDT), which has shown its efficacy and noninferiority to minocycline in a recent study.